302 related articles for article (PubMed ID: 8152567)
1. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
De Marinis L; Mancini A; Zuppi P; Fiumara C; Iacona T; Conte G; Fabrizi ML; Valle D; Anile C; Maira G
Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical growth hormone response to thyrotropin-releasing hormone in acromegaly. Clinical correlations and prognostic value.
De Marinis L; Mancini A; Zuppi P; Anile C; Maira G
Acta Endocrinol (Copenh); 1990 Apr; 122(4):443-9. PubMed ID: 2110409
[TBL] [Abstract][Full Text] [Related]
3. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
Tokuyama T; Yoshinari M; Okamura K; Ikenoue H; Sato K; Kuroda T; Fujishima M
Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):65-74. PubMed ID: 1674920
[TBL] [Abstract][Full Text] [Related]
4. Naloxone influence on the growth hormone, prolactin and thyrotropin response to thyrotropin releasing hormone in acromegalic patients.
De Marinis L; Mancini A; Zuppi P; Fiumara C; Conte G; Sammartano L; Fabrizi ML; Valle D
Exp Clin Endocrinol Diabetes; 1996; 104(1):67-71. PubMed ID: 8750573
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
[TBL] [Abstract][Full Text] [Related]
6. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly.
Watanobe H; Tamura T; Sasaki S; Takebe K
Neuropeptides; 1993 Dec; 25(6):363-75. PubMed ID: 8127416
[TBL] [Abstract][Full Text] [Related]
7. Paradoxic elevation in serum GH by hypothalamic releasing hormones predicts GH response to acute SMS 201-995 administration.
Candrina R
Recenti Prog Med; 1991 Jan; 82(1):13-6. PubMed ID: 1902962
[TBL] [Abstract][Full Text] [Related]
8. Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue.
Peracchi M; Molteni N; Cantalamessa L; Bardella MT; Peracchi G; Orsatti A; Faggioli P; Bianchi PA
Am J Gastroenterol; 1992 May; 87(5):580-3. PubMed ID: 1595643
[TBL] [Abstract][Full Text] [Related]
9. Do "so-called" normal growth hormone concentrations (2-5 micrograms/l) indicate cure in acromegaly?
Levitt NS; Ratanjee BD; Abrahamson MJ
Horm Metab Res; 1995 Apr; 27(4):185-8. PubMed ID: 7750902
[TBL] [Abstract][Full Text] [Related]
10. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
[TBL] [Abstract][Full Text] [Related]
11. TRH/GnRH test in acromegaly. Long-term follow-up experience with successfully treated patients.
Brockmeier SJ; Buchfelder M; Fahlbusch R
Horm Metab Res; 1993 May; 25(5):275-7. PubMed ID: 8330864
[TBL] [Abstract][Full Text] [Related]
12. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
Chang CC; Chen FW; Hsieh HC
Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
[TBL] [Abstract][Full Text] [Related]
13. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia.
Le Moli R; Endert E; Fliers E; Prummel MF; Wiersinga WM
Neth J Med; 2003 Feb; 61(2):44-8. PubMed ID: 12735420
[TBL] [Abstract][Full Text] [Related]
15. [Surgical results and clinical analysis of 19 cases of acromegaly].
Sugimoto S; Abe H; Kaneko S; Tokuda K; Aida T; Tsuru M; Nakagawa K; Akikawa K; Matsubara M
Hokkaido Igaku Zasshi; 1985 Mar; 60(2):241-51. PubMed ID: 3997057
[TBL] [Abstract][Full Text] [Related]
16. Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly.
Hanew K; Aida M; Tano T; Yoshinaga K
Tohoku J Exp Med; 1977 Mar; 121(3):197-206. PubMed ID: 404727
[TBL] [Abstract][Full Text] [Related]
17. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors.
Shi Y; Tang D; Deng J; Su C
Chin Med J (Engl); 1998 Oct; 111(10):891-4. PubMed ID: 11189233
[TBL] [Abstract][Full Text] [Related]
18. [Normalization of the GH response to L-DOPA in acromegalics after treatment with bromocriptine].
Carmina E; Lanzara P; Lo Coco R; Longo RA; Jannì A
Arch Sci Med (Torino); 1979; 136(3):421-5. PubMed ID: 549547
[TBL] [Abstract][Full Text] [Related]
19. Gsp mutation in acromegaly and its influence on TRH-induced paradoxical GH response.
Goto Y; Kinoshita M; Oshino S; Arita H; Kitamura T; Otsuki M; Shimomura I; Yoshimine T; Saitoh Y
Clin Endocrinol (Oxf); 2014 May; 80(5):714-9. PubMed ID: 24111551
[TBL] [Abstract][Full Text] [Related]
20. TRH-induced growth hormone release in insulin-dependent diabetes mellitus.
Krassowski J; Jeske W; Zgliczyński S
Horm Metab Res; 1984 Dec; 16 Suppl 1():119-22. PubMed ID: 6442706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
